BioCorRx (BICX) Long-Term Deferred Tax (2012 - 2025)

BioCorRx (BICX) posted Long-Term Deferred Tax of $13.2 million for Q4 2025, up 15.24% sequentially from $11.4 million in Q4 2023.

BioCorRx (BICX) Long-Term Deferred Tax (2012 - 2025) Analysis & Trends

BioCorRx has reported Long-Term Deferred Tax for 13 years, with the latest figure at $13.2 million in Q4 2025.

Quarterly Long-Term Deferred Tax changed N/A year-over-year to $13.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.2 million (changed N/A YoY) and the FY2025 annual result came in at $13.2 million, changed N/A from the prior year.
Long-Term Deferred Tax improved to $13.2 million in Q4 2025 per BICX's latest filing, from $11.4 million in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $13.2 million in Q4 2025 and troughed at $7.5 million in Q4 2021.
A 4-year average of $10.6 million and a median of $10.9 million in 2022 frame the typical range for Long-Term Deferred Tax.
The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax grew 3.84% in 2021, then soared 37.72% in 2022.
Over 4 years, Long-Term Deferred Tax stood at $7.5 million in 2021, then jumped by 37.72% to $10.3 million in 2022, then advanced by 10.56% to $11.4 million in 2023, then climbed by 15.24% to $13.2 million in 2025.
According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $13.2 million, $11.4 million, and $10.3 million for Q4 2025, Q4 2023, and Q4 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn
10	BioCorRx	1.49 Mn	1.47 Mn	-

Download Data